Hisham Abdel-Azim

Professor of Pediatrics, Medicine and Basic Sciences

Loma Linda University Cancer Center

United States

Hisham Abdel-Azim, MD is a Professor of Pediatrics, Medicine and Basic Sciences; Division Chief and Endowed Chair, Transplant and Cell Therapy/Hematological Malignancies, Director, Combined Adult and Pediatric Transplant and Cell Therapy Program; Director, Leukemia Research Program, Director of TCT/GMP lab, Loma Linda University Cancer Center, Loma Linda University School of Medicine, Children Hospital and Medical Center, Loma Linda, CA. Dr Abdel-Azim is physician and researcher who conduct laboratory research with aim of translating it into clinical applications; he is a principal and a co-principal investigator on several investigator-initiated and multi-center studies. He has authored more than 100 peer-reviewed journal articles and book chapters. His lab research is mainly focused on acute leukemia. Dr. Abdel-Azim is an expert in blood and marrow transplantation, cellular and immunotherapy for a wide variety of cancers, bone marrow disorders, and genetic and non-malignant diseases. He also has special expertise in laboratory assessment for minimal residual disease in blood cancers and immune recovery after blood and marrow transplantation. His research interests include infections in immune compromised host, reduction of transplant-associated complications, treatment of graft vs host disease, and use of cell therapy for treatment of malignant and non-malignant diseases.